DB Diagnostics

What DB Diagnostics does

DB Diagnósticos (legal entity Diagnósticos do Brasil Medicina Diagnóstica Ltda.) is a Brazilian privately held medical laboratory support company founded around 2012 by Tobias Martins. Operating exclusively as a B2B reference laboratory, the company processes diagnostic samples for 11,000+ partner laboratories across all 27 Brazilian states without competing with them — its stated differentiation is being the only lab in Brazil dedicated solely to laboratory support (apoio laboratorial). The company runs four specialized divisions: DB Molecular (molecular biology, genomics, cytogenetics, flow cytometry; 400,000+ tests/month), DB Patologia (anatomical pathology with digital pathology; 350,000+ tests/month, 50+ pathologists), DB Toxicológico (occupational toxicology and hair testing; 1M+ tests/month), and DB Genômica (precision genomics launched 2024-2025 covering oncogenetics, pharmacogenetics, fetal medicine, and rare diseases).

The technology stack is built around decentralized physical operations — 12 technical units and 40+ regional support units (URAs) with mirrored operations enabling a 24-hour nationwide sample logistics turnaround — combined with a menu of 5,000+ test types, digital pathology capabilities, and the recently deployed DIANA generative AI platform for commercial decision support. Quality infrastructure is anchored by ISO 9001, ISO/IEC 17025, DICQ, PALC, CAP, and GenQA certifications held across multiple units, providing both compliance coverage and competitive barriers. The technology footprint is geographically distributed, with the headquarters in São José dos Pinhais (Paraná) and a major technical hub in Sorocaba (São Paulo) housing DB Patologia and DB Molecular.

The business model is transaction-fee based: partner laboratories send samples to DB's regional units for processing and receive results through the UniDB client portal. Go-to-market is enterprise field sales with regional coverage across Brazil, supported by a consultative sales motion, scientific advisory boards, technical materials, and continuing medical education programs. The customer base is exclusively B2B (laboratories, healthcare professionals accessing through partner labs), with 20-25% annual growth reported and projected 2026 revenue of R$ 2.1 billion. Tobias Martins transitioned from commercial director to CEO in June 2026, signaling a strategic shift from expansion-led commercial focus to integrated operational leadership.

Name

DB Diagnostics

Legal name

Diagnósticos do Brasil Medicina Diagnóstica Ltda.

Website

https://diagnosticosdobrasil.com.br

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

DB Diagnósticos is a Brazilian B2B laboratory support company that processes diagnostic samples for 11,000+ partner laboratories across Brazil, operating 12 technical units and 40+ regional support units without competing with its clients.

Ownership category

akta.pro rank

Headquarters

HQ city

Sorocaba

HQ country

Brazil

HQ region

Latin America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Support Services: B2B laboratory support services where the company processes diagnostic samples for partner laboratories. Revenue generated through test processing fees, logistics services, and specialized diagnostic solutions. Model avoids competing with partner laboratories.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

DB Diagnósticos provides outsourced B2B laboratory support services (apoio laboratorial), processing diagnostic samples exclusively for partner laboratories across Brazil. The offering spans clinical analysis, molecular biology, genomics, anatomical pathology, toxicology, and precision genomics through four specialized units and 12 technical units with capacity for over 50 million exams monthly across a portfolio of more than 5,000 test types. The model is explicitly designed to avoid competing with partner laboratories by serving only as a back-end processing partner rather than a direct patient-facing lab.

Product overview

DB Diagnósticos operates as a laboratory support services company providing diagnostic testing exclusively to partner laboratories across Brazil through a multi-unit structure. The portfolio includes four specialized units: DB Molecular (genomics, cytogenetics, flow cytometry - 400,000+ tests/month), DB Patologia (anatomical pathology, digital pathology - 350,000+ tests/month), DB Genômica (precision genomics, pharmacogenetics, oncology), and DB Toxicológico (occupational toxicology, hair testing - 1M+ tests/month). The main services encompass a menu of over 5,000 test types including allergen testing (221 allergens), molecular biology, biochemistry, genetics, and clinical analyses, supported by national logistics integration and 12 technical units with capacity exceeding 50 million tests monthly.

Differentiator

Problem solved

Functional benefit

Brands

• DB Molecular: Specialized in Molecular Biology, Genomics, Cytogenetics, Cytogenomics and Flow Cytometry with capacity for over 400,000 exams per month.
• DB Genômica
• DB Patologia
• DB Toxicológico
• UniDB
• e-DB

Products and services

• DB Molecular Specialized B2B unit providing molecular biology solutions including Biologia Molecular, Genômica, Citogenética, Citogenômica and Citometria de Fluxo with capacity of 400,000+ exams per month and specialized scientific and medical advisory support for partner laboratories.
• DB Patologia Specialized B2B unit providing Anatomopathological, Cytopathological, Immunohistochemical and Molecular Pathology diagnostics with digital pathology technology, processing 350,000+ tests monthly through a team of 50+ medical pathologists for partner laboratories.
• DB Genômica Specialized B2B unit for precision genomics offering oncogenetics, onco-hematology, pharmacogenetics, microbiome analysis, preventive medicine, reproductive health, fetal medicine, and rare disease diagnostics with clinical-oriented reporting.
• DB Toxicológico Specialized B2B unit dedicated to occupational toxicology and wide detection window hair testing. Also offers clinical analysis tests for vitamins, biogenic amines, metals, and therapeutic drugs, with capacity of 1 million+ tests per month.
• Allergen Testing Portfolio (Alérgenos) B2B allergen testing portfolio covering 221 allergens with methodological flexibility (Fluoroenzymatic Immunoassay and Chemiluminescence) and national logistics integration for partner laboratories, supporting specific IgE detection.
• Laboratory Support Services (Apoio Laboratorial) Full-service B2B laboratory support (apoio laboratorial) providing diagnostic testing services exclusively to partner laboratories without competing with them. Offers 5,000+ different test types through 12 technical units and 40+ regional support units nationwide, with monthly capacity exceeding 50 million exams across all service lines.

Quantifiable outcome

• Processing capacity of 50 million tests per month
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Six partnerships are on record, tiered minor and core.

• S2 LabsminorOthersPart of the DB Universe network of specialized laboratory units, operating in the medical/scientific equipment or consumables space based on the website link to s2medica.com.br.
• DB MolecularcoreOthersSpecialized unit within Grupo DB focused on molecular biology, genomics, cytogenetics, cytogenomics, and flow cytometry diagnostics. Capacity of 400,000+ exams per month.
• DB GenômicacoreOthersSpecialized unit within Grupo DB dedicated to precision genomics including oncogenetics, pharmacogenetics, reproductive health, rare diseases, and clinical genetics.
• DB PatologiacoreOthersSpecialized unit within Grupo DB for anatomical pathology, cytopathology, immuno-histochemistry, and molecular pathology. Capacity of 350,000+ exams per month with 50+ pathologists.
• DB ToxicológicocoreOthersSpecialized unit within Grupo DB for occupational toxicology and wide detection window testing (hair test). Capacity of 1 million+ exams per month.
• HidrolaborminorOthersPart of the DB Universe network, operating in Maringá and Sorocaba locations. Related laboratory entity within the Grupo DB.

Scale indicators20 records

Recent moves8 records

Broad incumbents

• Dasa: Brazil's largest diagnostics company, operating a broad retail and hospital lab network. Highly comparable to DB Diagnósticos in core clinical diagnostics and specialty testing (molecular, genomics), but serves end-patients directly rather than operating as a B2B-only support partner.
• Eurofins Scientific: Global laboratory testing services group with strong clinical diagnostics and specialty testing operations across multiple geographies. Comparable to DB in decentralized, high-throughput lab operations and broad test portfolios serving B2B customers.
• Synlab: European leader in medical diagnostic services operating a hub-and-spoke reference lab network across multiple countries. Comparable to DB's national decentralized model serving partner laboratories and hospitals with high-volume specialty testing.
• Sonic Healthcare: Global reference laboratory operator with significant presence in Europe, Australia and the Americas. Comparable to DB in scale-driven B2B lab services, specialty testing (molecular, pathology, toxicology) and multi-site decentralized operations.
• Fleury: Major Brazilian medical diagnostics operator with extensive retail and reference-lab operations. Comparable to DB in specialty diagnostics (molecular, pathology, toxicology) and clinical analysis, but is a vertically integrated incumbent rather than an exclusive B2B support provider.
• Unilabs: Pan-European diagnostics provider with clinical lab and specialty testing (molecular, pathology, genetics) operations. Comparable to DB in operating a multi-country reference lab model serving partner clinicians and laboratories.

Regional players

• Grupo Oncoclínicas: Brazilian oncology-focused medical group with diagnostic and genomic testing capabilities for cancer care. Comparable to DB Genômica in precision oncology and molecular diagnostics, but focused on oncology rather than serving the full routine diagnostics market.

Direct peers

• Sabin Diagnóstico e Saúde: Brazilian diagnostics group with a national footprint of patient-facing labs and B2B reference lab services. Comparable to DB Diagnósticos in molecular diagnostics, pathology and specialty testing, and serves similar partner-lab and hospital customers.
• Hermes Pardini: Brazilian diagnostics company with strong specialty testing (molecular, genomics, pathology) and reference lab services. Highly comparable to DB's specialized divisions DB Molecular, DB Patologia and DB Genômica, particularly serving hospital and partner-lab customers.

Others

• Hospital Israelita Albert Einstein: Brazilian hospital system with a significant in-house and outreach diagnostics arm. Comparable to DB on quality benchmarks (CAP-equivalent standards) and specialty testing, but operates within a vertically integrated hospital ecosystem rather than as a pure B2B support provider.

Market position

Strengths5 records

Weaknesses5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCZ6gZ7Z3Qh5e9sIvKdLv2Ig
• LinkedInlinkedin.com/company/dbdiagnosticos
• Facebookfacebook.com/db.diagnosticos

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DB Diagnostics